Rajapharm International Marketplace Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 348.75%
- Profit Growth 147.44%
- Ebitda -59.69%
- Net Worth 28.82%
- Total Assets 4.91%
About Rajapharm International Marketplace
Rajapharm International Marketplace Private Limited (RIMPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 September 2020 (Four years and four months 18 days old ). Its registered office is in 24 Parganas, West Bengal, India.
The Company is engaged in the E-Commerce Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Nasra Bano and Ikbal Ahmad serve as directors at the Company.
Company Details
-
Location
24 Parganas, West Bengal, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U52520WB2020PTC239836
-
Company No.
239836
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 Sep 2020
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Rajapharm International Marketplace?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nasra Bano
|
Director | 17-Sep-2020 | Current |
|
Ikbal Ahmad
|
Director | 17-Sep-2020 | Current |
Financial Performance of Rajapharm International Marketplace.
Rajapharm International Marketplace Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 348.75% increase. The company also saw a substantial improvement in profitability, with a 147.44% increase in profit. The company's net worth Soared by an impressive increase of 28.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rajapharm International Marketplace?
Unlock access to Rajapharm International Marketplace's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rajapharm International Marketplace?
Rajapharm International Marketplace has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rajapharm International Marketplace, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rajapharm International Marketplace's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.